Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -148.44% is 89% above its 5-year average of -1410.82%, near the high end of its 5-year range (-4602.23%–224.98%).
2.37% below its 12-month average of -145.00%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2021 (2021-12-31): 224.98%.
EBITDA MARGIN
-148.44%
EBITDA MARGIN AVG TTM
-145.00%
EBITDA MARGIN AVG 3Y
-182.83%
EBITDA MARGIN AVG 5Y
-1410.82%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.37%
CURRENT VS 3Y AVG
+18.81%
CURRENT VS 5Y AVG
+89.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Decoy Therapeutics Inc.
Market Cap
$824550.00
EBITDA Margin
-148.44%
TTM Avg
-145.00%
3Y Avg
-182.83%
5Y Avg
-1410.82%
Market Cap
$835994.00
EBITDA Margin
-1.14%
TTM Avg
1.51%
3Y Avg
-2.34%
5Y Avg
-2.59%
Market Cap
$838843.00
EBITDA Margin
-3618.46%
TTM Avg
-3618.46%
3Y Avg
-3618.46%
5Y Avg
-3618.46%
Market Cap
$868077.00
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$901902.00
EBITDA Margin
1710.10%
TTM Avg
8440.35%
3Y Avg
4905.18%
5Y Avg
4832.78%
Market Cap
$946332.00
EBITDA Margin
-11.42%
TTM Avg
-13.72%
3Y Avg
-61.43%
5Y Avg
-349.42%
Market Cap
$667469.00
EBITDA Margin
-650.71%
TTM Avg
-399.98%
3Y Avg
-297.88%
5Y Avg
-236.24%
Market Cap
$1.01M
EBITDA Margin
-182712.72%
TTM Avg
-182712.72%
3Y Avg
-182712.72%
5Y Avg
-182712.72%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $824550.00 | -148.44% | -145.00% | -182.83% | -1410.82% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | -1.14% | 1.51% | -2.34% | -2.59% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | -3618.46% | -3618.46% | -3618.46% | -3618.46% |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 1710.10% | 8440.35% | 4905.18% | 4832.78% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $946332.00 | -11.42% | -13.72% | -61.43% | -349.42% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | -650.71% | -399.98% | -297.88% | -236.24% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -182712.72% | -182712.72% | -182712.72% | -182712.72% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-148.4%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2021-12-31 | 224.98% |
| 2021-06-30 | -544.64% |
| 2021-03-31 | -141.85% |
| 2020-12-31 | -118.49% |
| 2020-09-30 | -127.28% |
| 2020-06-30 | -138.15% |
| 2020-03-31 | -208.80% |
| 2019-12-31 | -197.92% |
| 2019-09-30 | -429.27% |
| 2019-06-30 | -146.87% |
| 2019-03-31 | -2102.55% |
| 2018-12-31 | -1208.05% |
| 2018-09-30 | -1041.32% |
| 2018-06-30 | -3683.78% |
| 2018-03-31 | -4602.23% |
| 2017-12-31 | -2835.28% |
| 2017-09-30 | -2255.80% |
| 2017-06-30 | -2621.94% |
| 2017-03-31 | -3403.42% |
| 2016-12-31 | -2633.76% |
| 2016-09-30 | -1779.38% |
| 2016-06-30 | -10127.17% |
